Abstract
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms and the selective loss of dopaminergic neurons. The etiology of idiopathic PD is likely a combination of genetic and environmental factors. Despite findings from mammalian studies that have provided significant insight into the disorder, the molecular mechanisms underlying its pathophysiology are still poorly understood. The nematode Caenorhabditis elegans (C. elegans) is a powerful system for genetic analysis. Considering C. elegans short lifespan, fully sequenced genome, high genetic and neurobiochemical conservation with humans, as well as the availability of facile genetic tools, the nematode represents a highly efficient and effective model system to explore the molecular basis of PD. In this review we describe the utility of C. elegans for PD research, and the opportunity the model system presents to identify therapeutic targets.
Keywords: Nematode, dopamine, Parkinson’s disease, neurodegeneration, neuroprotection, dopaminergic neurons, mammalian studies, pathophysiology, Caenorhabditis, therapeutic targets.
CNS & Neurological Disorders - Drug Targets
Title:C. elegans as a Genetic Model System to Identify Parkinson's Disease- Associated Therapeutic Targets
Volume: 11 Issue: 8
Author(s): Julia Vistbakka, Natalia VanDuyn, Garry Wong and Richard Nass
Affiliation:
Keywords: Nematode, dopamine, Parkinson’s disease, neurodegeneration, neuroprotection, dopaminergic neurons, mammalian studies, pathophysiology, Caenorhabditis, therapeutic targets.
Abstract: Parkinson’s disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms and the selective loss of dopaminergic neurons. The etiology of idiopathic PD is likely a combination of genetic and environmental factors. Despite findings from mammalian studies that have provided significant insight into the disorder, the molecular mechanisms underlying its pathophysiology are still poorly understood. The nematode Caenorhabditis elegans (C. elegans) is a powerful system for genetic analysis. Considering C. elegans short lifespan, fully sequenced genome, high genetic and neurobiochemical conservation with humans, as well as the availability of facile genetic tools, the nematode represents a highly efficient and effective model system to explore the molecular basis of PD. In this review we describe the utility of C. elegans for PD research, and the opportunity the model system presents to identify therapeutic targets.
Export Options
About this article
Cite this article as:
Vistbakka Julia, VanDuyn Natalia, Wong Garry and Nass Richard, C. elegans as a Genetic Model System to Identify Parkinson's Disease- Associated Therapeutic Targets, CNS & Neurological Disorders - Drug Targets 2012; 11 (8) . https://dx.doi.org/10.2174/1871527311211080004
DOI https://dx.doi.org/10.2174/1871527311211080004 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pulmonary Hypertension in COPD: Pathophysiology and Therapeutic Targets
Current Drug Targets Editorial [Hot Topic: Applications of Angiotensin Converting Enzyme Inhibitors and of Angiotensin II Receptor Blockers in Pharmacology and Therapy: An Update (Executive Editor: Agostino Molteni)]
Current Pharmaceutical Design Renal Sympathetic Denervation and Renal Physiology
Current Clinical Pharmacology Renal Complications of Fabry Disease
Current Pharmaceutical Design The Use of Propolis in Micro/Nanostructured Pharmaceutical Formulations
Recent Patents on Drug Delivery & Formulation Fetal Undernutrition and the Programming of Blood Pressure
Current Nutrition & Food Science Adrenomedullin Expression in Alzheimer's Brain
Current Alzheimer Research Atrial Tachycardias Occurring Late After Open Heart Surgery
Current Cardiology Reviews Gene Therapy and Biologic Therapy with Interleukin?4
Current Gene Therapy Treatment of Diabetic Foot Ulcer: An Overview Strategies for Clinical Approach
Current Diabetes Reviews The Emerging Role of Vascular Endothelial Growth Factor (VEGF) in Vascular Homeostasis: Lessons from Recent Trials with Anti-VEGF Drugs
Current Vascular Pharmacology Long-Term Effects of Perinatal Glucocorticoid Treatment on the Heart
Current Pediatric Reviews Vasopressin and Oxytocin in Control of the Cardiovascular System
Current Neuropharmacology Members of CRF Family and their Receptors: From Past to Future
Current Medicinal Chemistry Postprandial Hypotension - Novel Insights into Pathophysiology and Therapeutic Implications
Current Vascular Pharmacology Other Proteins Involved in Parkinson's Disease and Related Disorders
Current Protein & Peptide Science Urocortins: Take Them to Heart
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Clinical Significance of the Blood Pressure Changes from Day to Night
Current Hypertension Reviews Type 1 11 β-hydroxysteroid Dehydrogenase as Universal Drug Target in Metabolic Diseases?
Endocrine, Metabolic & Immune Disorders - Drug Targets Nociceptin /Orphanin FQ Peptide (NOP) Receptor Modulators: An Update in Structure-Activity Relationships
Current Medicinal Chemistry